Cargando…
Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial
PURPOSE: Identification of biomarkers to predict recurrence risk is essential to improve adjuvant treatment strategies in stage II/III gastric cancer patients. This study evaluated biomarkers for predicting survival after surgical resection. MATERIALS AND METHODS: This post-hoc analysis evaluated pa...
Autores principales: | Kim, Min Hwan, Zhang, Xianglan, Jung, Minkyu, Jung, Inkyung, Park, Hyung Soon, Beom, Seung-Hoon, Kim, Hyo Song, Rha, Sun Young, Kim, Hyunki, Choi, Yoon Young, Son, Taeil, Kim, Hyoung-Il, Cheong, Jae-Ho, Hyung, Woo Jin, Noh, Sung Hoon, Chung, Hyun Cheol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473262/ https://www.ncbi.nlm.nih.gov/pubmed/30282452 http://dx.doi.org/10.4143/crt.2018.331 |
Ejemplares similares
-
Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy
por: Kim, Hyo Song, et al.
Publicado: (2016) -
Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer
por: Kim, Hyo Song, et al.
Publicado: (2017) -
Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy
por: Beom, Seung-Hoon, et al.
Publicado: (2018) -
S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial
por: Lee, Choong-kun, et al.
Publicado: (2019) -
Modification of the TNM Staging System for Stage II/III Gastric Cancer Based on a Prognostic Single Patient Classifier Algorithm
por: Choi, Yoon Young, et al.
Publicado: (2018)